These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 6820658)
1. Surgery for a chronic cystic hematoma on the right thigh in a hemophiliac A with a potent factor VIII inhibitor. Masuhara K; Shimizu T; Kawasaki N; Fukui H; Sakai Y; Shima M; Mikami S; Yoshioka A Nihon Seikeigeka Gakkai Zasshi; 1982 Dec; 56(12):1719-27. PubMed ID: 6820658 [TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation]. Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611 [TBL] [Abstract][Full Text] [Related]
3. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia]. Meili EO; Dazzi H; von Felten A Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567 [TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine. Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361 [TBL] [Abstract][Full Text] [Related]
5. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management. Mahasandana C; Patharathienskul D; Suvatte V Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549 [TBL] [Abstract][Full Text] [Related]
6. Elective cardiac operation in a patient with severe hemophilia and acquired factor VIII antibodies. Leggett PL; Doyle D; Smith WB; Culpepper W; Cooper S; Ochsner JL J Thorac Cardiovasc Surg; 1984 Apr; 87(4):556-60. PubMed ID: 6423912 [TBL] [Abstract][Full Text] [Related]
7. [Factor VIII epitopes recognized by inhibitors in hemophiliacs]. Hayashi T; Niiya K; Sakuragawa N; Ichihara K; Yamazaki T; Watanabe A Rinsho Ketsueki; 1991 Sep; 32(9):945-50. PubMed ID: 1719257 [TBL] [Abstract][Full Text] [Related]
8. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital. Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560 [TBL] [Abstract][Full Text] [Related]
9. [Successfull extirpation of femoral pseudotumour in a patient with severe haemophilia A and an inhibitor to factor VIII]. Marisavljević D; Glisić M; Elezović I; Popović A; Rolović Z Srp Arh Celok Lek; 1991; 119(11-12):338-42. PubMed ID: 17974380 [TBL] [Abstract][Full Text] [Related]
10. [Perioperative management of ventricular septal defect and right coronary cusp prolapse in a patient with hemophilia A]. Nomura K; Nakamura Y; Yamagishi M; Yamamoto K; Hanada R Kyobu Geka; 1994 Dec; 47(13):1071-4. PubMed ID: 7830356 [TBL] [Abstract][Full Text] [Related]
11. The effect of non-activated prothrombin complex concentrate (Proplex ST) on intraperitoneal hematoma in a hemophilia A patient with a factor VIII inhibitor. Kagawa H; Yasuzawa M; Ozaki Y; Yamamoto Y; Katsurada T; Nomura S; Okubo S; Fukuhara S Intern Med; 1996 Apr; 35(4):319-22. PubMed ID: 8739790 [TBL] [Abstract][Full Text] [Related]
12. Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome. Yamamoto K; Niiya K; Shigematu T; Kiguchi T; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Shima M; Harada M Int J Hematol; 2000 Dec; 72(4):517-9. PubMed ID: 11197224 [TBL] [Abstract][Full Text] [Related]
13. [Acute and subacute intracranial hepatoma with hemophilia A--two cases report (author's transl)]. Toyama M; Ishikawa H; Ishii R; Okada K No Shinkei Geka; 1978 Mar; 6(3):275-9. PubMed ID: 76995 [TBL] [Abstract][Full Text] [Related]
14. Hemolysis caused by factor VIII concentrates. Orringer EP; Koury MJ; Blatt PM; Roberts HR Arch Intern Med; 1976 Sep; 136(9):1018-20. PubMed ID: 962445 [TBL] [Abstract][Full Text] [Related]
15. Treatment of anti-factor VIII antibodies. Blatt PM; White GC; McMillan CW; Roberts HR Thromb Haemost; 1977 Aug; 38(2):514-23. PubMed ID: 579493 [TBL] [Abstract][Full Text] [Related]
16. [Transient inhibitors developed in two cases of hemophilia A]. Fujiwara F; Kanoh G; Ogawa H; Takaya K; Hibi S; Shima M; Yoshioka A; Imashuku S Rinsho Ketsueki; 1997 Dec; 38(12):1263-8. PubMed ID: 9455145 [TBL] [Abstract][Full Text] [Related]
17. Idiopathic factor VIII inhibitor autoantibody in a man presented after accident. Mansouritorghabeh H; Lak M; van Heerde WL Clin Appl Thromb Hemost; 2009 Oct; 15(5):588-90. PubMed ID: 18550586 [TBL] [Abstract][Full Text] [Related]
18. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related]
19. Inhibitor antibodies to factor VIII and factor IX: management. Lusher JM Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411 [TBL] [Abstract][Full Text] [Related]
20. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]. Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]